|ALFVF -- USA Stock|| |
USD 26.30 1.35 4.88%
Mr. Ulf Wiinberg has served as Independent Member of the Board of Directors of Alfa Laval AB since April 23, 2013. He is Acting CEO of Hansa Medical AB. He is former Chief Executive Officer of H. Lundbeck AS. Formerly, he was also director of Wyeth Pharmaceuticals, EMEACanada BioPharma, and held a number of other senior positions in Wyeth. He currently serves as Chairman of Trialbee AB and Sigrid Therapeutics, as well as Board Member of UCB Pharma, Agenus Inc and Hansa Medical AB.
Age: 58 Director Since 2013
46 46 36 65 00 http://www.alfalaval.com